Infectious Disease Episodes

Dr. Matthew Pullen, infectious disease physician at the University of Minnesota, joins host Walker Redd to discuss blastomycosis, an often-overlooked endemic fungal infection. Through a case presentation, they explore epidemiology, classic histopathologic findings, and a variety of clinical manifestations, including pulmonary, cutaneous, CNS, and musculoskeletal. They also walk through diagnostic strategies and treatment approaches based on disease severity.

Dr. Vikramjit Mukherjee, critical care physician at NYU and Bellevue, joins Dr. Emily Gutowski for a review of septic shock management. They first review the diagnosis of SIRS vs. sepsis vs. severe sepsis vs. septic shock. Additional topics include identifying possible sources of infection, recognizing red flags, and initiating timely, adequate fluid resuscitation, including in special patient populations (e.g., CKD and CHF). Lastly, they briefly review the use of vasopressors in septic shock.

Dr. Sigal Yawetz, an infectious disease attending physician and medical educator at Brigham and Women’s Hospital chats with Blake Smith (host) about a career in infectious diseases. They talk together about the field of ID at large, in addition to sub-specializing, with a focus on the HIV patient population. Dr. Yawetz also comments on what it has been like living through two viruses that have shaped the globe - HIV and COVID - all through the lens of being an ID physician. The episode closes wi...

Dr. Michelle Cespedes, an infectious disease attending physician at Mount Sinai Hospital, is interviewed by host Emily Gutowski about the diagnosis of patients with HIV. They talk about both the acute presentation as well as the management of a patient with uncontrolled HIV.

Dr. Mikyung Lee, an infectious disease attending physician and program director for the ID fellowship at Mount Sinai Hospital, discusses hospital-acquired infections, including ventilator-acquired pneumonias and catheter-associated UTIs.

Dr. Sal Cilmi, an infectious disease attending physician and IM program director at Mount Sinai Hospital, discusses cellulitis and common culprits of soft tissue infections.

Dr. Solomon, an Infectious Diseases specialist at Brigham and Women's Hospital, discusses his approach to fever with host, Walker Redd. In discussing Dr. Solomon's framework for clinical reasoning in infectious diseases and applying it to a case of fever of unclear etiology, they ask: Who is the host? What are the notable exposures? What is the syndrome? What doesn't fit? Run the List podcast on AccessMedicine: https://accessmedicine.mhmedical.com/multimedia.aspx#1460

Dr. Marlise Luskin, a hematologist/oncologist at the Dana-Farber Cancer Institute, joins host Walker Redd and case presenter Jakub Glowala to discuss a case of a febrile neutropenia (FN) in a patient with AML. Dr. Luskin first defines neutropenia, then fever, and moves to the chronicity of FN. Using these definitions, Dr. Luskin talks about ways to identify which pathogens are more likely associated with acute vs. chronic FN presentations. They then walk through the standard workup of a patient ...

Dr. Ari Moskowitz, the Associate ICU Director in the division of pulmonary and critical care medicine at Beth Israel Deaconess Medical Center, talks with Dr. Navin Kumar about the management of patients with severe COVID-19. The two examine which patients require escalation to ICU-level care, in addition to the complications of severe COVID-19 and which organ systems can be affected. They discuss how to identify hypoxemic respiratory failure, the utility of the physical exam in the process, and ...

Dr. Mary Montgomery, an infectious disease physician at Brigham and Women’s Hospital, talks with Dr. Navin Kumar about the current COVID-19 pandemic. The two focus their discussion on inpatient diagnosis and management, covering the disease’s variable presentation, optimal time to test via nasopharyngeal swab, and current treatment paradigm from initial hospitalization to ICU. Possible therapeutic candidates, such as remdesivir, hydroxychloroquine, and IL-6 inhibitors, are also discussed.